Medical Device News Magazine

Stents Technologies and Global Markets 2022-2027

Greater Incidence of Non-Communicable/Chronic Diseases Fueling Growth

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Stents Technologies and Global Markets 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.

The global market for stents by vascular therapeutic application is estimated to increase from $7.1 billion in 2022 to $8.7 billion by 2027, at a CAGR of 4.2% during the forecast period of 2022 through 2027.

The global market for stents by nonvascular therapeutic application is estimated to increase from $760.4 million in 2022 to $970.5 million by 2027, at a CAGR of 5.0% during the forecast period of 2022 through 2027.

The global stents market is growing at a slow to moderate rate, with different devices on different swings. The peripheral vascular stents are on an upswing and are expected to see a high growth rate worldwide. U.S., Europe, and Japan are among the largest regions in terms of stents market share. These markets are reaching a point of saturation, where opportunity is focusing not on market penetration but rather on the opportunity to replace or shift to the newest generation of stents technology.

Report Scope

  • An up-to-date review of the global markets for stents and associated medical device technologies
  • Analyses of the global market trends, with revenue sales data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Evaluation and forecast of the global stents market size, forecasted growth trends, and corresponding market share analysis by product type, therapeutic application, and geographic region
  • Identification of promising new products (stents) and technologies that are still in development and assess the probability of their successful commercialization over the next few years
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of the global stents marketplace
  • Discussion of the regulatory structure for medical stents, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the medical devices industry
  • Insight into recent industry structure, the competitive landscape for major types of stents manufacturers, ongoing research activities and their clinical trials
  • Key merger and acquisition deals, product approvals/launches, agreements, collaborations, and other strategic alliances within the MedTech industry

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Regulatory Structure

Chapter 5 Market Breakdown by Application

  • Overview
  • Vascular
  • Coronary
  • Peripheral Vascular
  • Nonvascular
  • Ureteral
  • Gastrointestinal
  • Biliary and Pancreatic
  • Tracheobronchial/Pulmonary
  • Global Market for Stents, by Therapeutic Application
  • Global Market for Vascular Stents, by Therapeutic Application
  • Global Market for Coronary Stents
  • Global Market for Peripheral Vascular Stents, by Therapeutic Application
  • Global Market for Nonvascular Stents, by Therapeutic Application
  • Ureteral Stents
  • Gastrointestinal Stents
  • Biliary and Pancreatic Stents
  • Tracheobronchial/Pulmonary Stents

Chapter 6 Market Breakdown by Product Type

  • Overview
  • Stent Material
  • Bare-Metal Stent (BMS)
  • Drug-Eluting Stents (DES)
  • Drugs Used in DES
  • Polymer-Based DES
  • Polymer-Free DES (PF-DES)
  • Biodegradable/Bioabsorbable Stents (BDS)
  • Technological Advantages of BDS
  • Technological Disadvantages of BDS
  • Other Stents
  • Covered Stents
  • Plastic, Hybrid Material, and Silicone Stents
  • Global Market for Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Vascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Coronary Stents, by Stent Type
  • Global Market for Peripheral Vascular Stents, by Stent Type
  • Global Market for Nonvascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue

Chapter 7 Market Breakdown by Region

Chapter 8 Market Dynamics

  • Market Drivers
    • Favorable Global Demographics and Aging Population
    • Greater Incidence of Non-Communicable/Chronic Diseases
    • Continuous Product and Technology Developments
  • Other Drivers
  • Market Restraints
    • Alternative Technologies
    • Decline in Average Selling Prices
    • Stringent Regulatory Environment
    • Coverage and Reimbursement Issues
  • Other Restraints
  • Market Trends

Chapter 9 Competitive Landscape

  • Overview
  • Key Stent Manufacturers’ Offerings, by Application Types
  • Global Company Ranking
  • Coronary Stents
  • Peripheral Vascular Stents
  • Nonvascular Stents
  • Recent Industry Activities

Chapter 10 Company Profiles

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Becton, Dickinson And Co.
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Llc
  • Cordis Corp.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
  • W. L. Gore & Associates, Inc.

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”